果酱视频

Cariflex, a global producer of synthetic rubber latex, opened a new US$355 million (S$462 million) facility on Jurong Island on May 14, marking the launch of the world鈥檚 largest polyisoprene latex plant and Singapore鈥檚 first. The 6.1-hectare facility is expected to double the company鈥檚 global production capacity for polyisoprene latex once fully operational.

Speaking at the opening, Minister for Manpower and Second Minister for Trade and Industry Tan See Leng said the facility would enhance Singapore鈥檚 position in the specialty chemicals sector. Polyisoprene latex, a water-based synthetic material, is primarily used in surgical gloves and condoms due to its ability to reduce allergic reactions compared to natural rubber latex.

South-east Asia accounts for more than 75% of Cariflex鈥檚 global sales. Chief Operating Officer Philippe Henderson noted the new plant would strengthen the company鈥檚 supply chain and shorten delivery times to customers in the region. The COVID-19 pandemic highlighted the importance of resilient supply chains, and having a base in Singapore addresses that need, he said.

The facility has already created approximately 80 new jobs, with most roles filled by Singaporeans in areas such as engineering, production, and quality control. Dr. Tan said the job creation is significant, especially given the broader trend of automation reducing manpower needs in manufacturing. Cariflex plans to add about 40 more positions in the coming years, said Chief Executive Officer Ryu Sang Woo.

Ryu also emphasized the strategic importance of having manufacturing sites in both Brazil and Singapore. The dual-continent setup allows Cariflex to mitigate risks from geopolitical and trade tensions. 鈥淲e can supply our raw materials without disruption,鈥� he said, citing long-term supplier agreements in Asia.

Jurong Island was selected for its established chemical industry ecosystem, skilled labor pool, and advanced infrastructure. Ryu added that Singapore鈥檚 strong intellectual property protections, logistics network, and innovation capabilities made it an ideal choice for the investment.

Speaking about the impact of rising U.S. tariffs, Henderson noted that Cariflex does not supply directly to the U.S. but serves customers in South-east Asia who export to the American market. Ryu acknowledged that increased costs may eventually be passed to consumers and expressed hope that trade tensions will ease, especially given the critical medical applications of the company鈥檚 products.

Dr. Tan said Cariflex is part of Singapore鈥檚 growing specialty chemicals sector, which now contributes 20% of the country鈥檚 energy and chemicals output. 鈥淭his segment supports an innovation-led economy and helps diversify our manufacturing base,鈥� he said.